Association between the examination rate of treatment‐resistant schizophrenia and the clozapine prescription rate in a nationwide dissemination and implementation study

• Main Authors: Norio Yasui‐Furukori (Author), Hiroyuki Muraoka (Author), Naomi Hasegawa (Author), Shinichiro Ochi (Author), Shusuke Numata (Author), Hikaru Hori (Author), Akitoyo Hishimoto (Author), Toshiaki Onitsuka (Author), Kazutaka Ohi (Author), Naoki Hashimoto (Author), Tatsuya Nagasawa (Author), Yoshikazu Takaesu (Author), Takahiko Inagaki (Author), Hiromi Tagata (Author), Takashi Tsuboi (Author), Chika Kubota (Author), Ryuji Furihata (Author), Jun‐ichi Iga (Author), Hitoshi Iida (Author), Kenichiro Miura (Author), Junya Matsumoto (Author), Hisashi Yamada (Author), Koichiro Watanabe (Author), Ken Inada (Author), Kazutaka Shimoda (Author), Ryota Hashimoto (Author)
• Format: Book
• Published: Wiley, 2022-03-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.
• Notes: 2574-173X; 10.1002/npr2.12218
• Keywords: clozapine; examination rate; prescription rate; treatment‐resistant schizophrenia; Therapeutics. Pharmacology; RM1-950; Neurosciences. Biological psychiatry. Neuropsychiatry; RC321-571
• Source: Neuropsychopharmacology Reports, Vol 42, Iss 1, Pp 3-9 (2022)

Abstract Background The decision to initiate clozapine treatment should be made on an individual basis and may be closely related to the early detection of treatment‐resistant schizophrenia (TRS), although there is evidence that the early use of clozapine results in a better response to treatment. Therefore, we investigated the relationship between the examination rate of TRS and the prescription rate of clozapine. Methods After attending a 1‐day educational program on schizophrenia based on the "Guidelines for the Pharmacological Treatment of Schizophrenia," we asked the participating facilities to submit records of whether or not TRS was evaluated for each patient. We calculated the clozapine prescription rate from the schizophrenic patients prescribed clozapine and all of the schizophrenic patients. Forty‐nine facilities in 2017 were included in the study. Results There were dichotomous distributions in the examination rate of TRS and a non‐normal distribution in the prescription rate of clozapine. There was a significant correlation between the prescription rate of clozapine and the examination rate of TRS (r s = 0.531, P = 1.032 × 10−4). A significant difference was found in the prescription rate of clozapine between the three groups of facilities according to the examination rate of TRS. Conclusion As a preliminary problem for the use of clozapine, in Japan, the examination rate of TRS varies, and there are many facilities that typically do not consider the possibility of TRS; this trend leads to a low rate of clozapine use. Clearly, further clinician training is needed for the early detection and appropriate management of TRS that includes an explanation of TRS and how to introduce clozapine therapy to patients and their families.